| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Surgical Oncology (CCS, MIR, NM, JA, HMK, FM, FCA, LN, BF, SES, KKH) and Diagnostic Radiology (ED), The University of Texas M. D. Anderson Cancer Center, Houston, Texas.
Correspondence: Address correspondence and reprint requests to: Kelly K. Hunt, MD, M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 444, Houston, TX 77030; Fax: 713-792-4689; E-mail: khunt{at}mail.mdanderson.org
Background: In sentinel lymph node (SLN) biopsy for breast cancer, many centers use same-day preoperative injection of technetium 99mTc-labeled sulfur colloid and intraoperative injection of blue dye for localization of SLNs. Same-day sulfur colloid injections can be problematic because of the variability in sulfur colloid migration times, which can lead to ineffective use of operating room time, and low SLN-to-background radioactivity ratios. We examined the utility of day-before-surgery injections of high dose 99mTc-labeled sulfur colloid injections.
Methods: The day before surgery, high-dose 99mTc-labeled sulfur colloid was injected peritumorally, and a lymphoscintigram was obtained. Intraoperatively, after injection of blue dye, a gamma probe was used to localize SLNs. Nodes that were stained blue or were highly radioactive were considered SLNs and were removed.
Results: Lymphoscintigraphy demonstrated drainage in 107 patients (91%). Transcutaneous localization of the SLN was possible in 104 patients (89%). In three patients, all of whom had no drainage demonstrated on lymphoscintigraphy, no SLN was identified at surgery (97.5% success rate for SLN identification). A mean of 2.3 SLNs per patient were identified. Twenty-five patients (21%) had at least one histologically positive SLN. In 23 of these patients, the positive SLN was the SLN with the most radioactivity, and in the remaining two patients, the positive SLN was both blue-stained and hot.
Conclusion: Day-before-surgery injection of high-dose 99mTc-labeled sulfur colloid results in high rates of transcutaneous and intraoperative identification of SLNs. The delay between injection and surgery did not appear to promote significant passage of sulfur colloid to second-echelon nodes.
Key Words: Technetium 99m • Sulfur colloid • Biopsy • Sentinel lymph node • Breast cancer
This article has been cited by other articles:
 |
|
 |
|
  C. Tsopelas, E. Bevington, J. Kollias, S. Shibli, G. Farshid, B. Coventry, and B. E. Chatterton 99mTc-Evans Blue Dye for Mapping Contiguous Lymph Node Sequences and Discriminating the Sentinel Lymph Node in an Ovine Model Ann. Surg. Oncol., May 1, 2006; 13(5): 692 - 700. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Newman Sentinel Lymph Node Biopsy for Breast Cancer: Will Variations in Technique Influence Long-Term Outcome? Ann. Surg. Oncol., September 1, 2005; 12(9): 686 - 688. [Full Text] [PDF]
|
|
|
|
|
|
T. G. Zogakis, R. E. Wetherille, R. D. Christensen, K. J. Ose, J. D. Friedman, M. Colbert, C. A. Svendsen, O. K. Sanan, and T. M. Tuttle Intraoperative Subareolar Injection of 99mTc-Labeled Sulfur Colloid Results in Consistent Sentinel Lymph Node Identification Ann. Surg. Oncol., February 1, 2005; 12(2): 167 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S H Kim, J Shim, C K Kim, J Machac, and B R Krynyckyi Reverse echelon node and a lymphatic ectasia in the same patient during breast lymphoscintigraphy: the importance of injection and imaging technique Br. J. Radiol., December 1, 2004; 77(924): 1053 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. El-Tamer, R. Saouaf, T. Wang, and R. Fawwaz A New Agent, Blue and Radioactive, for Sentinel Node Detection Ann. Surg. Oncol., April 1, 2003; 10(3): 323 - 329. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
